Preladenant: an adenosine A_2A receptor antagonist for Parkinson’s disease

By Zúñiga-Ramírez Carlos   Micheli Federico  

Future Neurology, Vol. 8, Iss. 6, 2013-11 ,pp. : 639-648

Future Medicine

Access to resources Recommend Favorite

Persephin-Overexpressing Neural Stem Cells Regulate the Function of Nigral Dopaminergic Neurons and Prevent Their Degeneration in a Model of Parkinson's Disease

By Åkerud P.   Holm P.C.   Castelo-Branco G.   Sousa K.   Rodriguez F.J.   Arenas E.  

Molecular and Cellular Neuroscience, Vol. 21, Iss. 2, 2002-10 ,pp. : 205-222

Academic Press

Access to resources Recommend Favorite

Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease

By O’Keeffe Fiona E.  

Brain, Vol. 131, Iss. 3, 2008-03 ,pp. : 630-641

Oxford University Press

Access to resources Recommend Favorite

Embryonic and adult stem cells as a source for cell therapy in Parkinson’s disease

By Levy Yossef   Stroomza Merav   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 353-385

Humana Press, Inc

Access to resources Recommend Favorite

Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease

By Gołembiowska Krystyna  

Neurotoxicity Research, Vol. 24, Iss. 1, 2013-07 ,pp. : 29-40

Springer Publishing Company

Access to resources Recommend Favorite